Hanall Biopharma Co. Ltd. (009420)

Overview

Hanall Biopharma Co., Ltd. is a prominent pharmaceutical company based in South Korea, with a business reach that extends internationally. Founded in 1973, Hanall Biopharma has established itself as a significant player in the pharmaceutical industry, engaging in the manufacture and sale of a wide range of pharmaceutical products. The company's comprehensive portfolio includes prescription drugs as well as over-the-counter products, developed to address a vast spectrum of medical conditions and health concerns. Hanall Biopharma is dedicated to improving patients' lives by providing innovative and effective healthcare solutions, leveraging their extensive experience and expertise in the fields of ophthalmology, immunology, oncology, and neurology.

Products and Services

Hanall Biopharma Co., Ltd. offers a diverse array of pharmaceutical products catering to various health issues and medical conditions. These include:

• Prescription drugs and over-the-counter products: The company's offerings span a wide range of therapeutic areas, including but not limited to, treatments for diarrhea, prostatic hyperplasia, androgenetic alopecia (male pattern baldness), chronic renal failure, and hypoparathyroidism. Additionally, Hanall Biopharma's portfolio covers needs for vitamin D-resistant rickets, osteomalacia, osteoporosis, prostate cancer, liver diseases (toxic liver disease, chronic hepatitis, liver cirrhosis), functional dyspepsia, diabetes, peripheral vascular disorders, hypertension, and chronic heart failure, among others.
• Specialized health conditions treatments: The company addresses specific health issues such as skin diseases, hypoproteinemia, diabetic polyneuritis, various types of ulcers, high blood pressure, arthritis, endocrine disorders, spasms, insomnia, muscle pain, gastroesophageal reflux disease (GERD), allergic rhinitis, and dermatitis. It also covers chronic conditions like urticaria, cholesterol cholelithiasis (gallstones), gastritis, neurological diseases, erectile dysfunction, hyperphosphatemia, urinary tract infections, spastic paralysis, fungal infections, and menstrual pain, among others.
• Vitamins and dietary supplements: Emphasizing preventive healthcare and wellness, Hanall Biopharma provides supplements for deficiencies in vitamin D, vitamin B1, vitamin B12, and calcium. These essential nutrients support overall health, bone health, energy metabolism, and nerve function.
• Research and development: Hanall Biopharma is deeply invested in the research and development of innovative treatments, with promising therapeutic candidates in the pipeline. This includes HL192 for Parkinson's disease; HL036 for dry eye disease; HL161 for autoimmune conditions like myasthenia gravis, thyroid eye disease, warm autoimmune hemolytic anemia, neuromyelitis optica, immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy, and Graves' disease; as well as HL187 and HL186 for immuno-oncology applications. These developments underscore Hanall Biopharma's commitment to advancing medical science and delivering new treatment options to patients globally.